DCAT Value Chain Insights

Industry, FDA Meet Over Nitrosamine Impurities in APIs

A joint industry group of innovator and generic-drug makers and consumer healthcare companies met with the FDA to go over the challenges the industry is facing in implementing a FDA guidance for...

CDMOs/CMOs: The Top Moves Thus Far in 2021

What have been the key deals thus far in 2021 by CDMOs/CMOs? Biomanufacturing, including for cell- and gene-therapies, continues to be an active target for mergers and acquisitions. The largest deal...

SPONSORED CONTENT

Expand Opportunities with a Strong CMO Relationship

Information
July 28, 2021
Sponsored by CMIC CMO USA

Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A...

Read More
Advanced ODT Technologies for Drug Development in Japan and the US

Information
July 21, 2021
Sponsored by CMIC CMO USA

Since its introduction in the 1980s, the market for orally disintegrating tablets (ODTs) has grown annually, and ODTs are now available in a variety of therapeutic areas, both over-the-counter and...

Read More
Why Governments Need to Invest in Local Pharmaceutical Manufacturing, Research and Development

Information
July 7, 2021
Sponsored by CapsCanada

With much of the world now reliant on China and India for pharmaceuticals and the raw materials needed to make them, the risks of this reliance are now coming into sharp focus. In the past year...

Read More